The U.S. Food and Drug Administration (FDA) has approved Arcutis Biotherapeutics’ (NASDAQ: ARQT) New Drug Application (NDA) for ZORYVE (roflumilast) cream 0.3% for the treatment of plaque psoriasis in patients 12 years of age or older.
Newest Offering Features Pre-Chopped and Pre-Portioned Ingredients Ready to Combine, Bake and Serve
Blue Apron (NYSE:APRN) introduces a new line of Ready to Cook meals to meet growing customer demand for convenient,
On Thursday, Cathie Wood-led Ark Invest made a significant move by selling shares of Coinbase Global Inc (NASDAQ:COIN), despite the stock’s positive market performance on the same day.
The COIN Trade